Our R&D Centre in Hyderabad is built on a vast area, providing comprehensive infrastructure for groundbreaking innovation. This investment in infrastructure is key to our status as one of the top pharma companies in India.
As a global leader in developing and manufacturing a wide range of brands and generics, including oncology and ARV drugs, our commitment to innovation drives our progress. Our pharmaceutical company in Hyderabad plays a crucial role in bridging the gap between cutting-edge drug discovery and the real-world needs of patients.
Launched first generic 'COVIFOR' (Remdesivir) in India for the treatment of COVID-19 (licensing agreement with Gilead Sciences Inc.)
Basic manufacturer of Oseltamivir (sub-licensing agreement with Hoffman-La Rosche, Switzerland).
Click here for more...
In the pharmaceutical industry, innovation is at the core of what we do. At Hetero Healthcare, we develop new drugs and therapeutic biological products through structured innovation strategies, ensuring we meet the demand for pharmaceutical manufacturers in India.
We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. To be Recognized as an Innovative Pharmaceutical Company satisfying needs of the Customers, Doctors and Chemists.
Doctors
Formulation Products
Field Force
At Hetero Healthcare, our commitment to patient well-being extends beyond just providing innovative medications.
Read More
As a leading innovative pharmaceutical company in India, Hetero Healthcare recognizes its responsibility not just to improve human health but also to protect the planet.
Read More
Embarking on the path to parenthood is an exciting and significant chapter for many couples. But conception, the very foundation of this journey, can be a complex biological process.
Read More
Hetero Healthcare Gastrocare Division participated in 8th National Meeting of Colitis & Crohn’s Foundation (India), 2nd Round Table Meeting of BRICS IBD Consortium at Vizag from 4th - 6th October 2024.
Read More
Our Gastrocare Team of Hetero Healthcare held a Managers Development Program (MDP) in Mumbai from 12th to 14th September 2024 to enhance the Skills and Knowledge of Managers needed to lead effectively and drive organisational success.
Read More
ILCC 2024 was the third National conference of STII organised by ILBS. It was held on September 28th and 29th, 2024, at The Grand New Delhi.
Read More
DIAQUIL Launch: A New Breakthrough in Diabetic Foot Care by the DIASPA team at Hetero Healthcare
Read More
The Telangana team received Blazers from our beloved Director Mr. Namburi Bose and Assoc.
Read More
Congratulations, esteemed members of our exceptional KRIS Team!
Read MoreThis is to bring in your notice that multiple news items are going in and out about our product Covifor and becoming viral in social media. We want to inform the public that our organization did not create that news. We are here to serve our nation and citizens by making the product available across the country. For any patient support or inquiries, we made ourselves available through TOLL-FREE NUMBER 1800 103 4696 and EMAIL ID : covifor@heterohealthcare.com. We request all the patient caretakers to contact us on our toll-free number where we can support on a timely basis.
With the helping hands of our doctors, let us fight CORONA.
Copyright ©2025 澳洲幸运5开奖官网开奖记录-澳5幸运5开奖 All Rights Reserved by Hetero Healthcare Limited.
